Related Funds
Fund Name | Location |
Atos International | Chiba Prefecture, Japan, Tateyama |
BeeLabs | - |
Cohesive Capital | New York, New York, United States |
Columna Capital | England, London, United Kingdom |
CondeNet | California, San Francisco, United States |
CX Collective | Austin, Texas, United States |
Fishman Group | Michigan, Southfield, United States |
Foundation Equity Corp | Alberta, Canada, Saint Albert |
Goldstate Securities | China, Guangdong, Shenzhen |
Grower Venture Capital | China, Guangdong, Guangzhou |
JF2 Capital Partners | Dallas, Texas, United States |
Lennox Capital Partners | Dallas, Texas, United States |
Linkconn | China, Guangdong, Shenzhen |
MPcroissance | France, Midi-Pyrenees, Toulouse |
One Way Ventures | Boston, Massachusetts, United States |
STO Express | China, Qingpu, Shanghai |
Tau Investment Management | New York, New York, United States |
TechnoPlus Ventures | Israel, Tel Aviv, Tel Aviv District |
Techstars Chicago (Formerly Excelerate Labs) | Chicago, Illinois, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Hanhong Technology | $15M | 11 Dec 2023 | Xuhui, Shanghai, China | ||
$28M | 08 Jul 2020 | China, Shanghai | |||
Elpiscience Biopharmaceuticals | $100M | 28 Dec 2019 | Shanghai, China | ||
Cryofocus Biotech | $2M | 11 Dec 2018 | Shanghai, China | ||
14 Aug 2018 | Songjiang, Songjiang District, China | ||||
Weihansi Shengwu | $463K | 12 Jun 2018 | Shanghai, China | ||
INGEEK | $463K | 05 Jun 2018 | Xuhui, Shanghai, China | ||
HeRui BioMed | $1M | 23 May 2018 | Gusu District, Jiangsu, China | ||
Hongfund Financial | $463K | 27 May 2017 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Hanhong Technology | $15M | 11 Dec 2023 | Xuhui, Shanghai, China | ||
$28M | 08 Jul 2020 | China, Shanghai | |||
Elpiscience Biopharmaceuticals | $100M | 28 Dec 2019 | Shanghai, China | ||
Cryofocus Biotech | $2M | 11 Dec 2018 | Shanghai, China | ||
14 Aug 2018 | Songjiang, Songjiang District, China | ||||
Weihansi Shengwu | $463K | 12 Jun 2018 | Shanghai, China | ||
INGEEK | $463K | 05 Jun 2018 | Xuhui, Shanghai, China | ||
HeRui BioMed | $1M | 23 May 2018 | Gusu District, Jiangsu, China | ||
Hongfund Financial | $463K | 27 May 2017 | Shanghai, China |